The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Top Cited Papers
Open Access
- 15 March 2001
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (11), 824-831
- https://doi.org/10.1056/nejm200103153441108
Abstract
Combination antiretroviral therapy with a combination of three or more drugs has become the standard of care for patients with human immunodeficiency virus (HIV) infection in the United States. We estimated the clinical benefits and cost effectiveness of three-drug antiretroviral regimens.This publication has 39 references indexed in Scilit:
- Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000HIV Research & Clinical Practice, 2000
- Estimating the National Cost of Treating People With HIV Disease: Patient, Payer, and Provider DataJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Cost Effectiveness of Combination HIV TherapyPharmacoEconomics, 2000
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- A Randomized Trial of Daily and Thrice‐Weekly Trimethoprim‐Sulfamethoxazole for the Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus‐Infected PersonsClinical Infectious Diseases, 1999
- Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Combination Antiretroviral Therapy in HIV InfectionPharmacoEconomics, 1996
- Threshold Analysis and Programs for Prevention of HIV InfectionMedical Decision Making, 1995
- Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDSNew England Journal of Medicine, 1993